Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients
Clinical trial NCT02582684 · COMPLETED
Trial details
- NCT number
- NCT02582684
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-08
- Primary completion
- 2017-02-28
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.